Introduction: anti-IgE.
Bochner
Bruce
B
Division of Allergy and Clinical Immunology, Johns Hopkins Asthma and Allergy Center, USA.
Saini
Sarbjit
S
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy / Q000276:immunology; D002986:Clinical Trials as Topic; D005512:Food Hypersensitivity / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000503:physiopathology; D007073:Immunoglobulin E / Q000276:immunology*; D000069444:Omalizumab; D017455:Receptors, IgE / Q000502:physiology; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D017455:Receptors, IgE; D000069444:Omalizumab; D007073:Immunoglobulin E